Skip to main content
SpringerLink
Log in

The Methodology of the Collection of Adverse Event Data

  • Chapter
The Detection of New Adverse Drug Reactions

  • 74 Accesses

Abstract

In order to collect A.D.R. efficiently, it is necessary to know which factors might hinder their collection so that these can be circumvented. Between the advent of an adverse event and its final assessment as an A.D.R. the adverse event must be communicated.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Petrie, W.M. and Levine, J. The assessment of adverse reactions in clinical trials. Int. Pharmacopsychiat., 1978, 13, 209–216

    CAS  Google Scholar 

  2. Inman, W.H.W. The United Kingdom. In Monitoring for Drug Safety, M.T.P. Press, 1980

    Google Scholar 

  3. Gau, D.W. and Diehl, A.K. Disagreement among general practitioners regarding cause of death. Br. Med. J., 1982, 284, 239–242

    Article  CAS  Google Scholar 

  4. Cameron, H.M. and McGregor, E. Prospective study of 1152 hospital autopsies, 1: Inaccuracies in death certification. J. Pathol., 1981, 133, 273–283

    Article  CAS  PubMed  Google Scholar 

  5. Harlow, B.J. Monitoring of adverse reactions by a pharmaceutical company before marketing. In Adverse Drug Reactions (ed. D.J. Richards and R.K. Rondel), Churchill Livingstone, 1972

    Google Scholar 

  6. Downing, R.W., Rickets, K. and Meyers, F. Side reactions in neurotics, I: A comparison of two methods of assessment. J. Clin. Pharmacol., 1970, Sept-Oct., 289–297

    Google Scholar 

  7. Bulpitt, C.J. Randomised Controlled Clinical Trials, Martinus Nijhoff, The Hague, 1983

    Book  Google Scholar 

  8. Bulpitt, C.J., Dollery, C.T. and Carne, S. A symptom questionnaire for hypertensive patients. J. Chron. Dis., 1974, 27, 309–323

    Article  CAS  PubMed  Google Scholar 

  9. Howie, J.G.R. and Clark, G.A. Double blind trial of early demethylchlortetracycline in minor respiratory illness in general practice. Lancet, 1970, 2, 1009

    Google Scholar 

  10. Laferritre, N., Tenaillon, A., Saltiel, J. C., Smagghe, A., Chicon, F.J., Chretien, J. and Portos, J.L. Le questionnaire médical 1978, INSERM, Paris, 1977

    Google Scholar 

  11. Bond, A. and Lader, M. The use of analogue scales in rating subjective feelings. Br. J. Med. Psychol., 1974, 47, 211–218

    Article  Google Scholar 

  12. Aitken, R.C.B. Measurement of feelings using analogue scales. Proc. R. Soc. Med., 1969, 62, 989–993

    Google Scholar 

  13. Huskisson, E.C. Assessment for clinical trials. Clin. Rheumat. Dis., 1976, 2 (1), 37–49

    Google Scholar 

  14. McCavin, C.R., Artvinli, M., Nave, M. and McHardy, G.J.R. Dyspnoea, disability and distance walked. Comparison of estimates of exercise performance in respiratory disease. Br. Med. J., 1978, 2, 241–243

    Article  Google Scholar 

  15. Zealley, A.K. and Aitken, C.B. Measurement of mood. Proc. R. Soc. Med., 1969, 62, 993–996

    PubMed Central  CAS  PubMed  Google Scholar 

  16. Glaser, E.M. Volunteers, controls, placebos and questionnaires in clinical trials. In Medical Surveys and Clinical Trials (ed. L.J. Witts), Oxford Medical, 1964

    Google Scholar 

  17. Beck, A.T., Ward, C.M., Mendelsohn, M., Mock, J. and Erbaugh, J. An inventory for measuring depression. Arch. Gen. Psychiat., 1961, 4, 561–571

    Article  CAS  PubMed  Google Scholar 

  18. Hamilton, M.A. A rating scale for depression. J. Neurol. Neurosurg. Psychiat., 1960, 23, 56

    Article  Google Scholar 

  19. US Department of Health, Education and Welfare Alcohol, Drug Abuse and Mental Health Administration. Dotes. Dosage Record and Treatment Emergent Symptom Scale. In ECDEU Assessment Manual, p.223–245

    Google Scholar 

  20. Vinar, O. Scale for rating treatment emergent symptoms in psychiatry. Act. Nerv. Sup., 1971, 238–240

    Google Scholar 

  21. SAFTEE. A new method for assessing side effects in clinical trials. Cont. Clin. Trials, 1983, 4, 157

    Google Scholar 

  22. Anderson, K., Ma1m, U., Perris, C., Rapp, W. and Roman, G. The inter-rater reliability of scales for rating symptoms and side effects in schizophrenia patients during a clinical trial. Acta.Psychiat. Scand. Suppl., 1974, 249, 38–42

    Google Scholar 

  23. Gagnon, M.A. and Tebreault, L. Pharmacologie humainedes anorexigénes. Validité d’un questionnaire sur l’appetit. Un Med. Can., Vol. 104, Juin 1975, p.922–929

    CAS  Google Scholar 

  24. Pearson, R.G. and Byars, G.E. The development and validation of a checklist for measuring subjective fatigue. School of Aviation Medicine, USAF Report No. 56–115, 1956

    Google Scholar 

  25. Avery, C.W., Bertram, P.I., Allison, B. and Mandell, N. Systematic errors in the evaluation of side effects. Am. J. Psychiat., 1967, 123 (Jan.), 875–878

    Article  CAS  PubMed  Google Scholar 

  26. Downing, R.W., Rickets, K. and Meyers, F. Side reactions in neurotics: a comparison of two methods of assessment. J. Clin. Pharmacol., 1970, Sept-Oct., 289–297

    Google Scholar 

  27. Lapierre, Y.D. Evaluationdes effets secondaires chez les neurotiques. Un essai avec les mésoridazins et le placebo. Can. Psychiat. Ass. J., 1975, 26, 61–66

    Google Scholar 

  28. Greenblatt, M. Controls in clinical research. Clin. Pharmacol. Ther., 1964, 6 (2), 864–869

    Google Scholar 

  29. Huskisson, E.C. and Wojtulewski, J.A. Measurement of side effects of drugs. Br. Med. J., 1974, 2, 698–699

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  30. Ciccolunghi, S.N. and Chaudri, H.A. A methodological study of some factors influencing the reporting of symptoms. J. Clin. Pharmacol., 1975, July, 496–505

    Google Scholar 

  31. Lasagna, L. Bias in the elucidation of subjective side effects. Br. J. Clin. Pharmacol., 1981, 11, 111S–113S

    PubMed Central  PubMed  Google Scholar 

  32. New Zealand Hypertension Study Group. A multicentre open trial of labetalol in New Zealand. Br. J. Clin. Pharmacol., 1979, 179S-182S

    Google Scholar 

  33. Pessayre, D. and Benhamou, J.P. ‘Est-il possible et souhaitable de détecter 1’hépatotoxicité d’un médicament avant sa commercialisation’. Gastroenterol. Clin. Biol., 1981, 5, 60–563

    Google Scholar 

  34. Bulpitt, C.J. Quality of life in hypertensive patients. In Hypertensive Cardiovascular Disease: Pathophysiology and Treatment (ed. A. Amory), Martinus Nijhoff, The Hague, 1982

    Google Scholar 

  35. Jachuk, S.J., Brierley, H., Jachuk, S. and Willcox, P.M. The effect of hypotensive drugs on the quality of life. J. P. Coll. Gen. Pract., 1982, 32, 103–105

    Google Scholar 

  36. Sengupta, R.P., Chin, J. S. P. and Brierley, H. Quality of survival following direct surgery for anterior communicating artery aneurysm. J. Neurosurg., 1975, 43, 58–64

    Article  CAS  PubMed  Google Scholar 

Download references

Authors
  1. M. D. B. Stephens MB, BS, MRCGP, DRCOG, DMJ, Dip Pharm Med
    View author publications

    You can also search for this author in PubMed Google Scholar

Copyright information

© 1985 M.D.B. Stephens

About this chapter

Cite this chapter

Stephens, M.D.B. (1985). The Methodology of the Collection of Adverse Event Data. In: The Detection of New Adverse Drug Reactions. Palgrave Macmillan, London. https://doi.org/10.1007/978-1-349-07250-7_2

Download citation

Publish with us

Policies and ethics

Search

Navigation